Recent Findings from Oklahoma State University Has Provided New Information about Cancer (Assessing Patient Risk, Benefit, and Outcomes In Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer Indications)

Press/Media

Period26 Aug 2024

Media coverage

1

Media coverage

  • TitleRecent Findings from Oklahoma State University Has Provided New Information about Cancer (Assessing Patient Risk, Benefit, and Outcomes In Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer Indications)
    Media name/outletClinical Trials Daily
    Country/TerritoryUnited States
    Date26/08/24
    PersonsMatt Vassar
View all 1
View less

Related content